TGTX · TG Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Michael S. Weiss CEO and President | ▲ Buy | Grant | 9,778,086 Shares held | 1/8/2026 | View profile |
| Power Sean A CFO, Secretary and Treasurer | ▲ Buy | Grant | 798,111 Shares held | 1/8/2026 | View profile |
| Hoberman Kenneth Director | ▲ Buy | Grant | 279,653 Shares held | 6/12/2025 | View profile |
| Echelard Yann Director | ▼ Sell | Open Market | 223,816 Shares held | 11/24/2025 | View profile |
| HUME DANIEL Director | ▲ Buy | Grant | 192,748 Shares held | 6/12/2025 | View profile |
| Charney Laurence N Director | ▼ Sell | Open Market | 168,640 Shares held | 9/10/2026 | View profile |
| Lonial Sagar Director | ▼ Sell | Open Market | 94,061 Shares held | 9/11/2025 | View profile |
Transaction History
| Charney Laurence N | ▼ Sell | Open Market | 5,000 | $275K | 9/10/2026 |
| Charney Laurence N | ▼ Sell | Gift | 500 | $0 | 8/7/2026 |
| Charney Laurence N | ▼ Sell | Gift | 450 | $0 | 8/7/2026 |
| Charney Laurence N | ▼ Sell | Gift | 5,100 | $0 | 8/6/2026 |
| Charney Laurence N | ▼ Sell | Gift | 13,197 | $0 | 1/29/2026 |
| Charney Laurence N | ▼ Sell | Gift | 30,000 | $0 | 1/28/2026 |
| Michael S. Weiss | ▲ Buy | Grant | 622,000 | $0 | 1/8/2026 |
| Power Sean A | ▲ Buy | Grant | 90,000 | $0 | 1/8/2026 |
| Echelard Yann | ▼ Sell | Open Market | 5,000 | $163K | 11/24/2025 |
| Michael S. Weiss | ▼ Sell | Gift | 3,865,126 | $0 | 11/5/2025 |
| Michael S. Weiss | ▼ Sell | Gift | 803,717 | $0 | 11/5/2025 |
| Lonial Sagar | ▼ Sell | Open Market | 20,852 | $672K | 9/11/2025 |
| Echelard Yann | ▼ Sell | Open Market | 10,000 | $369K | 6/13/2025 |
| Hoberman Kenneth | ▲ Buy | Grant | 14,718 | $0 | 6/12/2025 |
| Echelard Yann | ▲ Buy | Grant | 14,718 | $0 | 6/12/2025 |
| HUME DANIEL | ▲ Buy | Grant | 14,718 | $0 | 6/12/2025 |
| Lonial Sagar | ▲ Buy | Grant | 14,718 | $0 | 6/12/2025 |
| Charney Laurence N | ▲ Buy | Grant | 21,408 | $0 | 6/12/2025 |
| HUME DANIEL | ▼ Sell | Gift | 62,459 | $0 | 3/17/2025 |
| Charney Laurence N | ▼ Sell | Gift | 6,000 | $0 | 3/10/2025 |
| Michael S. Weiss | ▲ Buy | Grant | 750,000 | $0 | 1/29/2025 |
| Power Sean A | ▲ Buy | Grant | 87,500 | $0 | 1/29/2025 |
| Power Sean A | ▼ Sell | Open Market | 10,021 | $286K | 1/6/2025 |
| Power Sean A | ▼ Sell | Open Market | 11,337 | $343K | 1/3/2025 |
| Charney Laurence N | ▼ Sell | Gift | 5,000 | $0 | 11/12/2024 |
| Lonial Sagar | ▼ Sell | Open Market | 5,000 | $152K | 11/11/2024 |
| Charney Laurence N | ▼ Sell | Open Market | 25,000 | $755K | 11/11/2024 |
| Echelard Yann | ▼ Sell | Open Market | 20,000 | $490K | 11/5/2024 |
| Lonial Sagar | ▼ Sell | Open Market | 16,348 | $276K | 6/20/2024 |
| Lonial Sagar | ▲ Buy | Grant | 22,250 | $0 | 6/19/2024 |
| HUME DANIEL | ▲ Buy | Grant | 22,250 | $0 | 6/19/2024 |
| Hoberman Kenneth | ▲ Buy | Grant | 22,250 | $0 | 6/19/2024 |
| Echelard Yann | ▲ Buy | Grant | 22,250 | $0 | 6/19/2024 |
| Charney Laurence N | ▲ Buy | Grant | 22,250 | $0 | 6/19/2024 |
| Lonial Sagar | ▼ Sell | Open Market | 9,585 | $157K | 6/17/2024 |
| Lonial Sagar | ▼ Sell | Open Market | 5,000 | $80K | 3/13/2024 |
| Charney Laurence N | ▼ Sell | Open Market | 22,000 | $351K | 3/12/2024 |
| Michael S. Weiss | ▲ Buy | Grant | 1,001,908 | $0 | 1/6/2024 |
| Charney Laurence N | ▼ Sell | Open Market | 17,500 | $333K | 1/5/2024 |
| Power Sean A | ▲ Buy | Grant | 75,000 | $0 | 1/5/2024 |
| Power Sean A | ▼ Sell | Open Market | 47,867 | $809K | 1/3/2024 |
| Hoberman Kenneth | ▲ Buy | Grant | 20,000 | $0 | 9/28/2023 |
| HUME DANIEL | ▲ Buy | Grant | 20,000 | $0 | 9/28/2023 |
| Lonial Sagar | ▲ Buy | Grant | 20,000 | $0 | 9/28/2023 |
| Charney Laurence N | ▲ Buy | Grant | 20,000 | $0 | 9/28/2023 |
| Echelard Yann | ▲ Buy | Grant | 20,000 | $0 | 9/28/2023 |
| Michael S. Weiss | ▲ Buy | Open Market | 100,000 | $1.0M | 8/11/2023 |
| Lonial Sagar | ▼ Sell | Open Market | 34,854 | $815K | 6/23/2023 |
| Power Sean A | ▼ Sell | Open Market | 73,647 | $2.0M | 6/2/2023 |
| Power Sean A | ▲ Buy | Grant | 85,000 | $0 | 3/12/2023 |
| Michael S. Weiss | ▲ Buy | Grant | 985,000 | $0 | 3/12/2023 |
| Echelard Yann | ▲ Buy | Open Market | 9,000 | $96K | 1/6/2023 |
| Charney Laurence N | ▼ Sell | Open Market | 30,000 | $333K | 1/4/2023 |
| Lonial Sagar | ▲ Buy | Grant | 43,732 | $0 | 7/20/2022 |
| HUME DANIEL | ▲ Buy | Grant | 43,732 | $0 | 7/20/2022 |
| Hoberman Kenneth | ▲ Buy | Grant | 43,732 | $0 | 7/20/2022 |
| Echelard Yann | ▲ Buy | Grant | 43,732 | $0 | 7/20/2022 |
| Charney Laurence N | ▲ Buy | Grant | 43,732 | $0 | 7/20/2022 |
| Power Sean A | ▲ Buy | Grant | 75,000 | $0 | 7/20/2022 |
| Power Sean A | ▼ Sell | Open Market | 9,653 | $177K | 1/5/2022 |
| Michael S. Weiss | ▼ Sell | Open Market | 30,671 | $562K | 1/5/2022 |
| Power Sean A | ▼ Sell | Open Market | 75,312 | $1.4M | 1/4/2022 |
| Michael S. Weiss | ▼ Sell | Open Market | 37,549 | $721K | 1/4/2022 |
| Michael S. Weiss | ▲ Buy | Grant | 56,394 | $0 | 12/29/2021 |
| Michael S. Weiss | ▼ Sell | Gift | 9,000 | $0 | 12/16/2021 |
| Michael S. Weiss | ▼ Sell | Gift | 700,000 | $0 | 12/16/2021 |
| Michael S. Weiss | ▼ Sell | Gift | 3,000 | $0 | 12/15/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
TGTX Highlighted as Affordable Biotech Growth Play
ChartMill recently featured TG Therapeutics as an affordable growth option within the biotech sector. This analysis suggests the stock may be viewed as undervalued relative to its potential, despite trading near its 52-week low. The mention adds a positive fundamental perspective to the current technical setup.
TGTX Highlighted as Affordable Biotech Growth Play. ChartMill recently featured TG Therapeutics as an affordable growth option within the biotech sector. This analysis suggests the stock may be viewed as undervalued relative to its potential, despite trading near its 52-week low. The mention adds a positive fundamental perspective to the current technical setup.